The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through ...
MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment ...
Metalla Royalty & Streaming Ltd. ("Metalla" or the "Company") (NYSE American: MTA) (TSXV: MTA) is pleased to announce preliminary and unaudited results for the year ended 2025 and to provide the ...
A staged roadmap turns pilots into lasting capability. Starting with low-complexity, high-impact use cases and scaling with ...